Crypto security technology

donedeal currently holds the mandate to raise capital for a Cybersecurity firm that designed and developed technologies around all circumstances where digital security and GDPR compliance could be impaired.

Key philosophy:

  • This encryption company has designed, built and integrated ● EASY TO IMPLEMENT, EASY TO USE, EASY TO MANAGE ● high-end military grade encryption which can be integrated to virtually ANY environment to protect the data AND ensure Data Reliability and Authenticity;
  • The company’s technology automatically encrypts emails, attachments, and MS Office documents and enables manual encryption of any kind of document or folder employing multi-factor authentication and military grade encryption;
  • Simplifying crypto security user experience, it allows users a constant peace of mind without fears for breach or exposure across the value chain as information remains encrypted while “at rest” or in transit;
  • Simple to implement and easy to use, it requires no changes to the client’s infrastructure and enables Zero Trust Security Models.

A meeting can be arranged if appropriate to discuss this opportunity and more generally The Capital D at your convenience.


Expert Cannabis Extraction Company

The donedeal team have been working for a while now on the first opportunity to present to The Capital D and donedeal currently holds the mandate to raise capital for an expert cannabis extraction company with a Germany focused implementation strategy:

  1. Sharp focus as a state-of-the-art ethanol extraction company with a positioning as a technology player in the market with the intent of becoming a leading provider of supreme CBD distillate and/or isolate products which will be supplied to distributors in Europe and beyond;
  2. Germany is a global leader across multiple industries and the forerunner of the European cannabis industry with stable & established legal & regulatory systems in respect of both CBD and THC;
  3. The company holds a trading licence for THC in Germany and is working on extending this licence, increasing capacity for full commercialisation;
  4. Take advantage of the opening of the European medicinal cannabis market by constantly monitoring the rapidly evolving European regulatory environment in order to maximise expansion in the medicinal cannabis market and engaged in several conversations, one of which has resulted in a (for the moment non-active) JV agreement with Zada;

A meeting can be arranged if appropriate to discuss this opportunity and more generally The Capital D at your convenience.